Intracranial hemangioblastoma – A SEER-based analysis 2004–2013
Metrics: PDF 1307 views | HTML 2063 views | ?
Ha Son Nguyen1,3, Ninh B. Doan1,5, Michael Gelsomino1, Saman Shabani1, Ahmed J. Awad1,4, Mayank Kaushal1 and Martin M. Mortazavi2,3
1Department of Neurosurgery, Medical College of Wisconsin, Milwaukee, Wisconsin, USA
2National Skull Base Center, Thousand Oaks, California, USA
3California Institute of Neuroscience, Thousand Oaks, California, USA
4Faculty of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine
5Department of Neurosurgery, University of South Alabama, Mobile, Alabama, USA
Ha Son Nguyen, email: [email protected]
Keywords: intracranial hemangioblastoma; SEER; surgery; radiation
Received: March 28, 2018 Accepted: May 14, 2018 Published: June 15, 2018
Introduction: Intracranial hemangioblastoma (HB) is a rare pathology. Limited data exist regarding its epidemiology.
Methods: With the SEER-18 registry database, information from all patients diagnosed with intracranial HB from 2004 to 2013 were extracted, including age, gender, race, marital status, presence of surgery, extent of surgery, receipt of radiation, tumor size, tumor location, and follow-up data. Age-adjusted incidence rates and overall survival (OS). Cox proportional hazards model was employed for both univariate and multivariate analyses.
Results: A total of 1307 cases were identified. The overall incidence of intracranial hemangioblastoma is 0.153 per 100,000 person-years [95% confidence interval (CI)=0.145–0.162]. Through univariate analysis, age < 40 [hazard ratio (HR)=0.277, p<0.001], no radiation [HR=0.56, p=0.047], and presence of surgery [HR=0.576, p=0.012] are significant positive prognostic factors. Caucasian race [HR=1.42, p=0.071] and female gender [HR=0.744, p=0.087] exhibit noticeable trends towards positive prognosis. Through multivariate analysis, younger age [HR=1.053, p < 0.01], race [HR=1.916, p<0.01], and presence of surgery [HR=0.463, p<0.01 were significant independent prognostic factors.
Conclusion: Clinical factors such as younger age, Caucasian race, and presence of surgery are significant independent factors for overall survival in patients with HBs. Though analysis regarding extent of surgery did not produce a meaningful relationship, this may be related to surgical bias / expertise. Moreover, no validation for radiation therapy was identified, but this may be related to short follow up intervals and the variable growth patterns of HBs.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.